Abstract
Seventy three children with rhabdomyosarcoma were treated by members of the Children's Solid Tumour Group during the period, 1974-1981. The extent of disease at diagnosis was found to be the major influence affecting outcome. Children with tumours confined to the tissue of origin with no evidence of nodal or metastatic spread, had a predicted actuarial 5-year survival rate of 86%. However children with 'unconfined' tumours, i.e. those with extension of disease outside the tissue of origin, had a much poorer prognosis with an actuarial 5-year survival rate of only 21%. Two other factors, histological type and site of primary tumour, appeared to affect prognosis but were not independent of the extent of disease at diagnosis. All children were treated according to protocol. Fifty-two patients showed a complete response to initial therapy and 4 of the 11 partial responders achieved a full remission after additional therapy. The overall complete response rate was therefore 77%. Nineteen children who achieved a complete response on initial treatment subsequently relapsed. Only 3 of these children were alive with no evidence of disease 3 years later, a salvage rate of 15%. "Late" relapses, defined as those occurring more than 2 years after diagnosis, were seen in only 5 children, 4 in boys with primary paratesticular tumours.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Donaldson S. S., Castro J. R., Wilbur J. R., Jesse R. H., Jr Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. Cancer. 1973 Jan;31(1):26–35. doi: 10.1002/1097-0142(197301)31:1<26::aid-cncr2820310105>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- Ehrlich F. E., Haas J. E., Kiesewetter W. B. Rhabdomyosarcoma in infants and children: factors affecting long-term survival. J Pediatr Surg. 1971 Oct;6(5):571–577. doi: 10.1016/0022-3468(71)90381-2. [DOI] [PubMed] [Google Scholar]
- Grosfeld J. L., Clatworthy H. W., Jr, Newton W. A., Jr Combined therapy in childhood rhabdomyosarcoma: an analysis of 42 cases. J Pediatr Surg. 1969 Dec;4(6):637–645. doi: 10.1016/0022-3468(69)90491-6. [DOI] [PubMed] [Google Scholar]
- Han M. T., Telander R. L., Pairolero P. C., Payne W. S., Gilchrist G. S., Sim F. H., Pritchard D. J. Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents. J Pediatr Surg. 1981 Dec;16(6):928–933. doi: 10.1016/s0022-3468(81)80848-2. [DOI] [PubMed] [Google Scholar]
- Heyn R. M., Holland R., Newton W. A., Jr, Tefft M., Breslow N., Hartmann J. R. The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children. Cancer. 1974 Dec;34(6):2128–2142. doi: 10.1002/1097-0142(197412)34:6<2128::aid-cncr2820340638>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- Jaffe N., Filler R. M., Farber S., Traggis D. G., Vawter G. F., Tefft M., Murray J. E. Rhabdomyosarcoma in children. Improved outlook with a multidisciplinary approach. Am J Surg. 1973 Apr;125(4):482–487. doi: 10.1016/0002-9610(73)90087-1. [DOI] [PubMed] [Google Scholar]
- Kilman J. W., Clatworthy H. W., Jr, Newton W. A., Jr, Grosfeld J. L. Reasonable surgery for rhabdomyosarcoma: a study of 67 cases. Ann Surg. 1973 Sep;178(3):346–351. doi: 10.1097/00000658-197309000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawrence W., Jr, Hays D. M., Moon T. E. Lymphatic metastasis with childhood rhabdomyosarcoma. Cancer. 1977 Feb;39(2):556–559. doi: 10.1002/1097-0142(197702)39:2<556::aid-cncr2820390226>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Malpas J. S., Freeman J. E., Paxton A., Smith J. W., Stansfeld A. G., Wood C. B. Radiotherapy and adjuvant combination chemotherapy for childhood rhabdomyosarcoma. Br Med J. 1976 Jan 31;1(6004):247–249. doi: 10.1136/bmj.1.6004.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maurer H. M., Moon T., Donaldson M., Fernandez C., Gehan E. A., Hammond D., Hays D. M., Lawrence W., Jr, Newton W., Ragab A. The intergroup rhabdomyosarcoma study: a preliminary report. Cancer. 1977 Nov;40(5):2015–2026. doi: 10.1002/1097-0142(197711)40:5<2015::aid-cncr2820400505>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Neifeld J. P., Maurer H. M., Godwin D., Berg J. W., Salzberg A. M. Prognostic variables in pediatric rhabdomyosarcoma before and after multi-modal therapy. J Pediatr Surg. 1979 Dec;14(6):699–703. doi: 10.1016/s0022-3468(79)80248-1. [DOI] [PubMed] [Google Scholar]
- Pratt C. B., Hustu H. O., Fleming I. D., Pinkel D. Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Cancer Res. 1972 Mar;32(3):606–610. [PubMed] [Google Scholar]
- Pratt C. B. Response of childhood rhabdomyosarcoma to combination chemotherapy. J Pediatr. 1969 May;74(5):791–794. doi: 10.1016/s0022-3476(69)80145-9. [DOI] [PubMed] [Google Scholar]
- Sutow W. W., Lindberg R. D., Gehan E. A., Ragab A. H., Raney R. B., Jr, Ruymann F., Soule E. H. Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1982 Jun 1;49(11):2217–2221. doi: 10.1002/1097-0142(19820601)49:11<2217::aid-cncr2820491102>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Sutow W. W., Sullivan M. P., Ried H. L., Taylor H. G., Griffith K. M. Prognosis in childhood rhabdomyosarcoma. Cancer. 1970 Jun;25(6):1384–1390. doi: 10.1002/1097-0142(197006)25:6<1384::aid-cncr2820250617>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- Tefft M., Hays D., Raney R. B., Jr, Lawrence W., Soule E., Donaldson M. H., Sutow W. W., Gehan E. Radiation to regional nodes for rhabdomyosarcoma of the genitourinary tract in children: is it necessary? A report from the Intergroup Rhabdomyosarcoma Study No. 1 (IRS-1). Cancer. 1980 Jun 15;45(12):3065–3068. doi: 10.1002/1097-0142(19800615)45:12<3065::aid-cncr2820451231>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]